Relenza Indications/Uses

Treatment of influenza: RELENZA is indicated for treatment of both influenza A and B in adults and children (≥5 years) who present with symptoms typical of influenza when influenza is circulating in the community.
Prevention of influenza: RELENZA is indicated for post-exposure prophylaxis of influenza A and B in adults and children (≥5 years) following contact with a clinically diagnosed case in a household (see Pharmacology: Pharmacodynamics under Actions for children aged 5-11 years). In exceptional circumstances, RELENZA may be considered for seasonal prophylaxis of influenza A and B during a community outbreak (e.g. in case of a mismatch between circulating and vaccine strains and a pandemic situation).
RELENZA is not a substitute for influenza vaccination. The appropriate use of RELENZA for prevention of influenza should be determined on a case-by-case basis depending on the circumstances and the population requiring protection.
The use of antivirals for the treatment and prevention of influenza should take into consideration official recommendations, the variability of epidemiology, and the impact of the disease in different geographical areas and patient populations.